🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07020182
Starting soon Not applicable

Efficacy Of Inpatient Pulmonary Rehabilitation Program In Elderly Patients With Acute Exacerbation Of COPD

NCT07020182 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-06-10
Last updated
2025-06-13

Condition(s) studied

COPD Received PRElderly (People Aged 65 or More)COPDCOPD Acute Exacerbation

Investigational drug(s) / intervention(s)

physical therapy program

physical therapy program: Group A will performed a physical therapy program that completed two daily sessions till discharge from the hospital .Exercise training starts from randomisation until hospital discharge,and administered twice per day, seven times per week. The study will be start from day 1 of hospital admission till discharge from the hospital.The study duration will be 12 weeks

Study summary

The study aimed to identify the effect of early pulmonary rehabilitation in elderly patients with Acute exacerbation (AE) of COPD (AECOPD) in exercise tolerance, dyspnea, sleep quality, fatigue, and time to discharge from hospital.

Eligibility

Sex
ALL
Min age
65 Years
Max age
78 Years
Healthy volunteers
No
Inclusion Criteria: * Patients with acute exacerbation of COPD in both gender * Patient older than 65 years * Patient with clear consciousness * Patients had been diagnosed with shortness of breath or dyspnea that was not caused by heart disease, pneumothorax, or pulmonary edema Exclusion Criteria: * Patient with systolic blood pressure lower than 90 mmHg * Patient with an unstable psychological status, hemoptysis, pneumothorax, pulmonary edema

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Medicine for Girls- Al-Azhar-University, Cairo, Egypt Cairo Egypt

More Al-Azhar University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07020182 on ClinicalTrials.gov ↗ ← All trials in Egypt